Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 12, 2015, Pages 1394-1409

  Romero, Roberto ^a,b,c   Miranda, Jezid ^a,d   Chaemsaithong, Piya ^a,d   Chaiworapongsa, Tinnakorn ^a,d   Kusanovic, Juan P ^a,e,f   Dong, Zhong ^a   Ahmed, Ahmed I ^a,d   Shaman, Majid ^a,d   Lannaman, Kia ^a,d   Yoon, Bo Hyun ^g   Hassan, Sonia S ^a,d   Kim, Chong Jai ^a,h   Korzeniewski, Steven Jai ^a,c,d   Yeo, Lami ^a,d   Kim, Yeon Mee ^a,i  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g Seoul National University College of Medicine   (South Korea)

^h University of Ulsan College of Medicine   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

Author keywords

Infection; polymerase chain reaction with electrospray ionization mass spectrometry; pregnancy; prematurity; preterm delivery; Sneathia sp.

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; AEROBIC BACTERIUM; AMNION FLUID; AMNION FLUID ANALYSIS; AMNIONITIS; ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM; CHORIOAMNIONITIS; COHORT ANALYSIS; CONTROLLED STUDY; CULTURE TECHNIQUE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNISITIS; GESTATIONAL AGE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MYCOPLASMA; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SNEATHIA; UREAPLASMA UREALYTICUM; CHEMISTRY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; AMNIOTIC FLUID; CHORIOAMNIONITIS; COHORT STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INTERLEUKIN-6; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; UREAPLASMA UREALYTICUM;

EID: 84940783253     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.958463     Document Type: Article

References (279)

1. rd ed. Malden, MA: Blackwell; 2008:1130-88.
2. Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am 2005;32:411-28.
3. rd JF. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-70.
4. Gibbs RS, Blanco JD. Premature rupture of the membranes. Obstet Gynecol 1982;60:671-9.
5. Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol 1984;64:615-20.
6. Gomez R, Romero R, Edwin SS, et al. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135-76.
7. Romero R, Quintero R, Oyarzun E, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;159:661-6.
8. Maxwell GL. Preterm premature rupture of membranes. Obstet Gynecol Surv 1993;48:576-83.
9. Lee T, Silver H. Etiology and epidemiology of preterm premature rupture of the membranes. Clin Perinatol 2001;28:721-34.
10. Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG 2006;113:17-42.
11. Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
12. Iams JD, Romero R, Culhane JF, et al. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008;371:164-75.
13. Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol 2009;201:230-40.
14. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010;362:529-35.
15. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing - The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738-45.
16. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-93.
17. Wilson JC, Levy DL, Wilds PL. Premature rupture of membranes prior to term: consequences of nonintervention. Obstet Gynecol 1982;60:601-6.
18. Cox SM, Williams ML, Leveno KJ. The natural history of preterm ruptured membranes: what to expect of expectant management. Obstet Gynecol 1988;71:558-62.
19. Nelson LH, Anderson RL, O'Shea TM, et al. Expectant management of preterm premature rupture of the membranes. Am J Obstet Gynecol 1994;171:350-6; discussion 356-8.
20. Johnson JW, Daikoku NH, Niebyl JR, et al. Premature rupture of the membranes and prolonged latency. Obstet Gynecol 1981;57:547-56.
21. Daikoku NH, Kaltreider DF, Khouzami VA, et al. Premature rupture of membranes and spontaneous preterm labor: maternal endometritis risks. Obstet Gynecol 1982;59:13-20.
22. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261-9.
23. Tsiartas P, Kacerovsky M, Musilova I, et al. The association between histological chorioamnionitis, funisitis and neonatal outcome in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2013;26:1332-6.
24. Garite TJ, Freeman RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982;59:539-45.
25. Cotton DB, Hill LM, Strassner HT, et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984;63:38-43.
26. Zlatnik FJ, Cruikshank DP, Petzold CR, et al. Amniocentesis in the identification of inapparent infection in preterm patients with premature rupture of the membranes. J Reprod Med 1984;29:656-60.
27. Broekhuizen FF, Gilman M, Hamilton PR. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol 1985;66:316-21.
28. Feinstein SJ, Vintzileos AM, Lodeiro JG, et al. Amniocentesis with premature rupture of membranes. Obstet Gynecol 1986;68:147-52.
29. Dudley J, Malcolm G, Ellwood D. Amniocentesis in the management of preterm premature rupture of the membranes. Aust NZ J Obstet Gynaecol 1991;31:331-6.
30. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839-51.
31. Font GE, Gauthier DW, Meyer WJ, et al. Catalase activity as a predictor of amniotic fluid culture results in preterm labor or premature rupture of membranes. Obstet Gynecol 1995;85:656-8.
32. Yoon BH, Jun JK, Park KH, et al. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol 1996;88:1034-40.
33. Blackwell SC, Berry SM. Role of amniocentesis for the diagnosis of subclinical intra-amniotic infection in preterm premature rupture of the membranes. Curr Opin Obstet Gynecol 1999;11:541-7.
34. Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med 2012;17:12-19.
35. Ecker DJ, Sampath R, Blyn LB, et al. Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance. Proc Natl Acad Sci USA 2005;102:8012-17.
36. Ecker DJ, Sampath R, Willett P, et al. The Microbial Rosetta Stone Database: a compilation of global and emerging infectious microorganisms and bioterrorist threat agents. BMC Microbiol 2005;5:19.
37. Sampath R, Hofstadler SA, Blyn LB, et al. Rapid identification of emerging pathogens: coronavirus. Emerg Infect Dis 2005;11:373-9.
38. Hofstadler SA, Sampath R, Blyn LB, et al. TIGER: the universal biosensor. Int J Mass Spectrom 2005;242:23-41.
39. Ecker JA, Massire C, Hall TA, et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 2006;44:2921-32.
40. Blyn LB, Hall TA, Libby B, et al. Rapid detection and molecular serotyping of adenovirus by use of PCR followed by electrospray ionization mass spectrometry. J Clin Microbiol 2008;46:644-51.
41. Ecker DJ, Massire C, Blyn LB, et al. Molecular genotyping of microbes by multilocus PCR and mass spectrometry: a new tool for hospital infection control and public health surveillance. Methods Mol Biol 2009;551:71-87.
42. Hujer KM, Hujer AM, Endimiani A, et al. Rapid determination of quinolone resistance in Acinetobacter spp. J Clin Microbiol 2009;47:1436-42.
43. Ecker DJ, Sampath R, Li H, et al. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev Mol Diagn 2010;10:399-415.
44. Kaleta EJ, Clark AE, Cherkaoui A, et al. Comparative analysis of PCR-electrospray ionization/mass spectrometry (MS) and MALDITOF/MS for the identification of bacteria and yeast from positive blood culture bottles. Clin Chem 2011;57:1057-67.
45. Massire C, Ivy CA, Lovari R, et al. Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry. J Clin Microbiol 2011;49:908-17.
46. Gu Z, Hall TA, Frinder M, et al. Evaluation of repetitive sequence PCR and PCR-mass spectrometry for the identification of clinically relevant Candida species. Med Mycol 2012;50:259-65.
47. Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 2012;14:295-304.
48. Bhatia NS, Farrell JJ, Sampath R, et al. Identification of Streptococcus intermedius central nervous system infection by use of PCR and electrospray ionization mass spectrometry. J Clin Microbiol 2012;50:4160-2.
49. Schuetz AN, Huard RC, Eshoo MW, et al. Identification of a novel Acinetobacter baumannii clone in a US hospital outbreak by multilocus polymerase chain reaction/electrospray-ionization mass spectrometry. Diagn Microbiol Infect Dis 2012;72:14-19.
50. Metzgar D, Frinder M, Lovari R, et al. Broad-spectrum biosensor capable of detecting and identifying diverse bacterial and Candida species in blood. J Clin Microbiol 2013;51:2670-8.
51. Brinkman CL, Vergidis P, Uhl JR, et al. PCR-Electrospray ionization mass spectrometry for direct detection of pathogens and antimicrobial resistance from heart valves in patients with infective endocarditis. J Clin Microbiol 2013;51:2040-6.
52. Farrell JJ, Sampath R, Ecker DJ, et al. "Salvage microbiology": detection of bacteria directly from clinical specimens following initiation of antimicrobial treatment. PLoS One 2013;8:e66349.
53. Jordana-Lluch E, Carolan HE, Gimenez M, et al. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLoS One 2013;8:e62108.
54. Romero R, Miranda J, Chaiworapongsa T, et al. A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol 2014;71:330-58.
55. Romero R, Miranda J, Chaiworapongsa T, et al. Sterile intra-amniotic inflammation is more frequent than microbial-associated intra-amniotic inflammation in preterm labor with intact membranes. Am J Reprod Immunol (Submitted). 2014. [Epub ahead of print].
56. Romero R, Miranda J, Chaiworapongsa T, et al. Rapid diagnosis of microbial invasion of the amniotic cavity in asymptomatic patients with a sonographic short cervix. J Matern Fetal Neonatal Med (submitted). 2014;1-52.
57. Romero R, Miranda J, Kusanovic JP, et al. The microbiology of clinical chorioamnionitis at term: a study based on cultivation and molecular microbiologic techniques. J Matern Fetal Neonatal Med (accepted). 2014.
58. rd LC, Hankins GD, et al. Term maternal and neonatal complications of acute chorioamnionitis. Obstet Gynecol 1985;66:59-62.
59. Gibbs RS, Dinsmoor MJ, Newton ER, et al. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol 1988;72:823-8.
60. DiGiulio DB, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One 2008;3:e3056.
61. DiGiulio DB, Romero R, Kusanovic JP, et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol 2010;64:38-57.
62. DiGiulio DB, Gervasi M, Romero R, et al. Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods. J Perinat Med 2010;38:503-13.
63. DiGiulio DB, Gervasi MT, Romero R, et al. Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses. J Perinat Med 2010;38:495-502.
64. Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130-6.
65. Kim KW, Romero R, Park HS, et al. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2007;197:292 e291-5.
66. Redline RW, Heller D, Keating S, et al. Placental diagnostic criteria and clinical correlation - a workshop report. Placenta 2005;26:S114-17.
67. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med 2006;11:296-301.
68. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25.
69. Eshoo MW, Crowder CC, Rebman AW, et al. Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease. PLoS One 2012;7:e36825.
70. Shin JH, Ranken R, Sefers SE, et al. Detection, identification, and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus PCR coupled with electrospray ionization/mass spectrometry. J Clin Microbiol 2013;51:136-41.
71. A broad range of tests to meet your needs. Available from: www.athogen.com/consulting-services/microbial-tests.html [last accessed Sep 2014].
72. Legoff J, Feghoul L, Mercier-Delarue S, et al. Broad-range PCR/electrospray ionization mass spectrometry for detection and typing of adenovirus and other opportunistic viruses in stem cell transplant patients. J Clin Microbiol 2013;51:4186-92.
73. Romero R, Avila C, Santhanam U, et al. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990;85:1392-400.
74. Santhanam U, Avila C, Romero R, et al. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 1991;3:155-63.
75. Romero R, Sepulveda W, Kenney JS, et al. Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Found Symp 1992;167:205-20; discussion 220-30.
76. Romero R, Yoon BH, Kenney JS, et al. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993;30:167-83.
77. Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805-16.
78. Gomez R, Romero R, Galasso M, et al. The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994;32:200-10.
79. Romero R, Galasso M, Gomez R, et al. A comparative study of the value of amniotic fluid interleukin-6, white blood cell count and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients with spontaneous labor at term. Annual Meeting of the Society of Perinatal Obstetricians; 1994; Las Vegas, NV. A250 p.
80. Andrews WW, Hauth JC, Goldenberg RL, et al. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995;173:606-12.
81. Yoon BH, Romero R, Kim CJ, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960-70.
82. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30.
83. Yoon BH, Romero R, Park JS, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998;179:1254-60.
84. Yoon BH, Romero R, Moon JB, et al. The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin. Am J Obstet Gynecol 2001;185:1137-42.
85. Yoon BH, Romero R, Lim JH, et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003;189:919-24.
86. Madan I, Romero R, Kusanovic JP, et al. The frequency and clinical significance of intra-amniotic infection and/or inflammation in women with placenta previa and vaginal bleeding: an unexpected observation. J Perinat Med 2010;38:275-9.
87. Gervasi MT, Romero R, Bracalente G, et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (432 weeks) preterm delivery. J Perinat Med 2012;40:329-43.
88. Romero R, Kadar N, Miranda J, et al. The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6. J Matern Fetal Neonatal Med 2014;27:757-69.
89. Romero R, Manogue KR, Mitchell MD, et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:336-41.
90. Romero R, Mazor M, Sepulveda W, et al. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992;166:1576-87.
91. Romero R, Mazor M, Brandt F, et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992;27:117-23.
92. Hillier SL, Witkin SS, Krohn MA, et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81:941-8.
93. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
94. Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93.
95. Athayde N, Romero R, Maymon E, et al. Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2000;182:135-41.
96. Leslie KK, Lee SL, Woodcock SM, et al. Acute intrauterine infection results in an imbalance between pro- and anti-inflammatory cytokines in the pregnant rabbit. Am J Reprod Immunol 2000;43:305-11.
97. Blank V, Hirsch E, Challis JR, et al. Cytokine signaling, inflammation, innate immunity and preterm labour - a workshop report. Placenta 2008;29:S102-4.
98. Ilievski V, Hirsch E. Synergy between viral and bacterial toll-like receptors leads to amplification of inflammatory responses and preterm labor in the mouse. Biol Reprod 2010;83:767-73.
99. Cobo T, Kacerovsky M, Palacio M, et al. Intra-amniotic inflammatory response in subgroups of women with preterm prelabor rupture of the membranes. PLoS One 2012;7:e43677.
100. Cobo T, Kacerovsky M, Holst RM, et al. Intra-amniotic inflammation predicts microbial invasion of the amniotic cavity but not spontaneous preterm delivery in preterm prelabor membrane rupture. Acta Obstet Gynecol Scand 2012;91:930-5.
101. Kacerovsky M, Musilova I, Jacobsson B, et al. Cervical and vaginal fluid soluble Toll-like receptor 2 in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2014. [Epub ahead of print].
102. Cobo T, Jacobsson B, Kacerovsky M, et al. Systemic and local inflammatory response in women with preterm prelabor rupture of membranes. PLoS One 2014;9:e85277.
103. Kacerovsky M, Musilova I, Jacobsson B, et al. Vaginal fluid IL-6 and IL-8 levels in pregnancies complicated by preterm prelabor membrane ruptures. J Matern Fetal Neonatal Med 2014. [Epub ahead of print].
104. Kacerovsky M, Musilova I, Jacobsson B, et al. Cervical fluid IL-6 and IL-8 levels in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2014. [Epub ahead of print].
105. Kacerovsky M, Musilova I, Hornychova H, et al. Bedside assessment of amniotic fluid interleukin-6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol 2014. [Epub ahead of print].
106. Kacerovsky M, Musilova I, Andrys C, et al. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am J Obstet Gynecol 2014;210:325 e321-e310.
107. Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014;210:125 e121-e125.
108. Romero R, Ceska M, Avila C, et al. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991;165:813-20.
109. Cherouny PH, Pankuch GA, Romero R, et al. Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993;169:1299-303.
110. Romero R, Gomez R, Galasso M, et al. Macrophage inflammatory protein-1 alpha in term and preterm parturition: effect of microbial invasion of the amniotic cavity. Am J Reprod Immunol 1994;32:108-13.
111. Cohen J, Ghezzi F, Romero R, et al. GRO alpha in the fetomaternal and amniotic fluid compartments during pregnancy and parturition. Am J Reprod Immunol 1996;35:23-9.
112. Hsu CD, Meaddough E, Aversa K, et al. The role of amniotic fluid L-selectin, GRO-alpha, and interleukin-8 in the pathogenesis of intraamniotic infection. Am J Obstet Gynecol 1998;178:428-32.
113. Esplin MS, Romero R, Chaiworapongsa T, et al. Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection. J Matern Fetal Neonatal Med 2005;17:365-73.
114. Gotsch F, Romero R, Kusanovic JP, et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008;21:529-47.
115. Romero R, Quintero R, Emamian M, et al. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1454-60.
116. Romero R, Emamian M, Wan M, et al. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1461-7.
117. Romero R, Wu YK, Sirtori M, et al. Amniotic fluid concentrations of prostaglandin F2 alpha, 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) and 11-deoxy-13,14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2 (PGEM-LL) in preterm labor. Prostaglandins 1989;37:149-61.
118. Mazor M, Wiznitzer A, Maymon E, et al. Changes in amniotic fluid concentrations of prostaglandins E2 and F2 alpha in women with preterm labor. Isr J Med Sci 1990;26:425-8.
119. Mazaki-Tovi S, Romero R, Kusanovic JP, et al. Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med 2008;36:485-96.
120. Soto E, Romero R, Richani K, et al. Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection. J Matern Fetal Neonatal Med 2009;22:983-92.
121. Vaisbuch E, Romero R, Erez O, et al. Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2009;22:905-16.
122. Kacerovsky M, Musilova I, Khatibi A, et al. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2012;25:2014-19.
123. Kacerovsky M, Drahosova M, Krejsek J, et al. Amniotic fluid CD200 levels in pregnancies complicated by preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2013;26:1416-24.
124. Andrys C, Kacerovsky M, Drahosova M, et al. Amniotic fluid soluble Toll-like receptor 2 in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2013;26:520-7.
125. Rosen T, Schatz F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002;11:11-17.
126. Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004;191:1996-2001.
127. Lockwood CJ, Toti P, Arcuri F, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005;167:1443-9.
128. Stephenson CD, Lockwood CJ, Ma Y, et al. Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. J Matern Fetal Neonatal Med 2005;18:17-22.
129. Erez O, Romer R, Vaisbuch E, et al. Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation. J Matern Fetal Neonatal Med 2009;22:971-82.
130. Erez O, Romero R, Vaisbuch E, et al. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor. J Matern Fetal Neonatal Med 2010;23:23-33.
131. Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998;179:1248-53.
132. Maymon E, Romero R, Pacora P, et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol 2000;183:914-20.
133. Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;183:94-9.
134. Maymon E, Romero R, Pacora P, et al. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 2000;182:1545-53.
135. Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med 2001;29:308-16.
136. Helmig BR, Romero R, Espinoza J, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med 2002;12:237-46.
137. Park KH, Chaiworapongsa T, Kim YM, et al. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 2003;31:12-22.
138. Petersen LK, Helmig R, Oxlund H, et al. Relaxin (hRLX-2)-induced weakening of human fetal membranes in vitro. Eur J Obstet Gynecol Reprod Biol 1994;57:123-8.
139. Lei H, Furth EE, Kalluri R, et al. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 1996;98:1971-8.
140. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-6.
141. Moore RM, Mansour JM, Redline RW, et al. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 2006;27:1037-51.
142. Kumar D, Fung W, Moore RM, et al. Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol Reprod 2006;74:29-34.
143. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol 2007;21:467-78.
144. rd JF. Extracellular matrix dynamics and fetal membrane rupture. Reprod Sci 2013;20:140-53.
145. Lonergan M, Aponso D, Marvin KW, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab 2003;88:3835-44.
146. Maymon E, Edwin S, Gomez R, et al. Evidence for dysreglation in the death factor receptor:Fas in premature labor. Am J Obstet Gynecol 1999;180:S26.
147. Maymon E, Edwin S, Pacora P, et al. A role of the cell death factor system (Fas/Fas ligand) in spontaneous rupture of membranes. Am J Obstet Gynecol 1999;180:S19.
148. Romero R, Chaiworapongsa T, Espinoza J, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002;187:1125-30.
149. Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296-302.
150. Wang H, Ogawa M, Wood JR, et al. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet 2008;17:1087-96.
151. Wang H, Parry S, Macones G, et al. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 2004;13:2659-69.
152. Ferrand PE, Parry S, Sammel M, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494-501.
153. Wang H, Parry S, Macones G, et al. A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A 2006;103:13463-7.
154. Wang H, Sammel MD, Tromp G, et al. A 12-bp deletion in the 5′-flanking region of the SERPINH1 gene affects promoter activity and protects against preterm premature rupture of membranes in African Americans. Hum Mutat 2008;29:332.
155. Sachs BP, Stern CM. Activity and characterization of a low molecular fraction present in human amniotic fluid with broad spectrum antibacterial activity. Br J Obstet Gynaecol 1979;86:81-6.
156. Hadi HA, Hodson CA, Strickland D. Premature rupture of the membranes between 20 and 25 weeks' gestation: role of amniotic fluid volume in perinatal outcome. Am J Obstet Gynecol 1994;170:1139-44.
157. Espinoza J, Chaiworapongsa T, Romero R, et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003;13:2-21.
158. Akinbi HT, Narendran V, Pass AK, et al. Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 2004;191:2090-6.
159. Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10:294-302.
160. Carroll SG, Ville Y, Greenough A, et al. Preterm prelabour amniorrhexis: intrauterine infection and interval between membrane rupture and delivery. Arch Dis Child Fetal Neonatal Ed 1995;72:F43-6.
161. Carroll SG, Nicolaides KH. Fetal haematological response to intra-uterine infection in preterm prelabour amniorrhexis. Fetal Diagn Ther 1995;10:279-85.
162. Murphy DJ, Sellers S, MacKenzie IZ, et al. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995;346:1449-54.
163. Watterberg KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-15.
164. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-40.
165. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997;278:207-11.
166. Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-11.
167. Sampson JE, Theve RP, Blatman RN, et al. Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 1997;176:77-81.
168. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
169. Dammann O, Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 1998;5:190-201.
170. Yoon BH, Romero R, Kim KS, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-9.
171. Leviton A, Paneth N, Reuss ML, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999;46:566-75.
172. Gravett MG, Hitti J, Hess DL, et al. Intrauterine infection and preterm delivery: evidence for activation of the fetal hypothalamic-pituitary-adrenal axis. Am J Obstet Gynecol 2000;182:1404-13.
173. Jobe AH, Newnham JP, Willet KE, et al. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am J Obstet Gynecol 2000;182:401-8.
174. Dammann O, Phillips TM, Allred EN, et al. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001;13:234-9.
175. Kramer BW, Moss TJ, Willet KE, et al. Dose and time response after intraamniotic endotoxin in preterm lambs. Am J Respir Crit Care Med 2001;164:982-8.
176. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001;2:27-32.
177. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001;79:205-9.
178. Willet KE, Kramer BW, Kallapur SG, et al. Intra-amniotic injection of IL-1 induces inflammation and maturation in fetal sheep lung. Am J Physiol Lung Cell Mol Physiol 2002;282:L411-20.
179. Moon JB, Kim JC, Yoon BH, et al. Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy. J Perinat Med 2002;30:301-6.
180. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29-38.
181. Romero R, Espinoza J, Goncalves LF, et al. Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2004;16:146-57.
182. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns - dry numbers, wet lab, and causal inferences. Early Hum Dev 2004;79:1-15.
183. Wharton KN, Pinar H, Stonestreet BS, et al. Severe umbilical cord inflammation - a predictor of periventricular leukomalacia in very low birth weight infants. Early Hum Dev 2004;77:77-87.
184. Witt A, Berger A, Gruber CJ, et al. IL-8 concentrations in maternal serum, amniotic fluid and cord blood in relation to different pathogens within the amniotic cavity. J Perinat Med 2005;33:22-6.
185. Dammann O, Leviton A, Gappa M, et al. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG 2005;112:4-9.
186. Moss TJ, Nitsos I, Ikegami M, et al. Experimental intrauterine Ureaplasma infection in sheep. Am J Obstet Gynecol 2005;192:1179-86.
187. Jobe AH. Antenatal associations with lung maturation and infection. J Perinatol 2005;25:S31-5.
188. Hagberg H, Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 2005;18:117-23.
189. Kim YM, Romero R, Chaiworapongsa T, et al. Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Toll-like receptors in epidermal keratinocytes. Histopathology 2006;49:506-14.
190. Dammann O, Leviton A. Inflammation, brain damage and visual dysfunction in preterm infants. Semin Fetal Neonatal Med 2006;11:363-8.
191. Di Naro E, Cromi A, Ghezzi F, et al. Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am J Obstet Gynecol 2006;194:153-9.
192. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006;11:354-62.
193. Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007;50:652-83.
194. Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008;198:43 e41-5.
195. Moss TJ, Knox CL, Kallapur SG, et al. Experimental amniotic fluid infection in sheep: effects of Ureaplasma parvum serovars 3 and 6 on preterm or term fetal sheep. Am J Obstet Gynecol 2008;198:122 e121-8.
196. Kramer BW, Kallapur SG, Moss TJ, et al. Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep. Innate Immun 2009;15:101-7.
197. Madsen-Bouterse SA, Romero R, Tarca AL, et al. The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 2010;63:73-92.
198. Romero R, Savasan ZA, Chaiworapongsa T, et al. Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med 2011;40:19-32.
199. Leviton A, Hecht JL, Allred EN, et al. Persistence after birth of systemic inflammation associated with umbilical cord inflammation. J Reprod Immunol 2011;90:235-43.
200. Kemp MW, Saito M, Nitsos I, et al. Exposure to in utero lipopolysaccharide induces inflammation in the fetal ovine skin. Reprod Sci 2011;18:88-98.
201. Leviton A, O'Shea TM, Bednarek FJ, et al. Systemic responses of preterm newborns with presumed or documented bacteraemia. Acta Paediatr 2012;101:355-9.
202. Kacerovsky M, Cobo T, Andrys C, et al. The fetal inflammatory response in subgroups of women with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2013;26:795-801.
203. Leviton A, Fichorova RN, O'Shea TM, et al. Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res 2013;73:362-70.
204. Kuban KC, O'Shea TM, Allred EN, et al. Systemic inflammation and cerebral palsy risk in extremely preterm infants. J Child Neurol 2014. [Epub ahead of print].
205. Dammann O, Leviton A. Intermittent or sustained systemic inflammation and the preterm brain. Pediatr Res 2014;75:376-80.
206. Hanff PA, Rosol-Donoghue JA, Spiegel CA, et al. Leptotrichia sanguinegens sp. nov., a new agent of postpartum and neonatal bacteremia. Clin Infect Dis 1995;20:S237-9.
207. De Martino SJ, Mahoudeau I, Brettes JP, et al. Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery. J Clin Microbiol 2004;42:5940-3.
208. Harwich Jr MD, Serrano MG, Fettweis JM, et al. Genomic sequence analysis and characterization of Sneathia amnii sp. nov. BMC Genomics 2012;13:S4.
209. Gauthier DW, Meyer WJ, Bieniarz A. Correlation of amniotic fluid glucose concentration and intraamniotic infection in patients with preterm labor or premature rupture of membranes. Am J Obstet Gynecol 1991;165:1105-10.
210. Romero R, Mazor M, Morrotti R, et al. Infection and labor. VII. Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Am J Obstet Gynecol 1992;166:129-33.
211. Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000;183:1130-7.
212. Shim SS, Romero R, Hong JS, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191:1339-45.
213. Olomu IN, Hecht JL, Onderdonk AO, et al. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics 2009;123:1329-36.
214. Jacobsson B, Aaltonen R, Rantakokko-Jalava K, et al. Quantification of Ureaplasma urealyticum DNA in the amniotic fluid from patients in PTL and pPROM and its relation to inflammatory cytokine levels. Acta Obstet Gynecol Scand 2009;88:63-70.
215. Kim M, Kim G, Romero R, et al. Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J Perinat Med 2003;31:146-52.
216. Gomez R, Romero R, Nien JK, et al. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005;18:31-7.
217. Hassan S, Romero R, Hendler I, et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006;34:13-19.
218. Oh KJ, Lee SE, Jung H, et al. Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency. J Perinat Med 2010;38:261-8.
219. Kacerovsky M, Celec P, Vlkova B, et al. Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria. PLoS One 2013;8:e60399.
220. Horowitz S, Mazor M, Romero R, et al. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995;40:375-9.
221. Gray DJ, Robinson HB, Malone J, et al. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111-17.
222. van Rensburg HJ, Odendaal HJ. The prevalence of potential pathogenic micro-organisms in the endocervix of pregnant women at Tygerberg Hospital. S Afr Med J 1992;81:156-7.
223. Smith CV, Horenstein J, Platt LD. Intraamniotic infection with Candida albicans associated with a retained intrauterine contraceptive device: a case report. Am J Obstet Gynecol 1988;159:123-4.
224. Chaim W, Mazor M, Wiznitzer A. The prevalence and clinical significance of intraamniotic infection with Candida species in women with preterm labor. Arch Gynecol Obstet 1992;251:9-15.
225. Donders GG, Moerman P, Caudron J, et al. Intra-uterine Candida infection: a report of four infected fetusses from two mothers. Eur J Obstet Gynecol Reprod Biol 1991;38:233-8.
226. Romero R, Reece EA, Duff GW, et al. Prenatal diagnosis of Candida albicans chorioamnionitis. Am J Perinatol 1985;2:121-2.
227. Berry DL, Olson GL, Wen TS, et al. Candida chorioamnionitis: a report of two cases. J Matern Fetal Med 1997;6:151-4.
228. Qureshi F, Jacques SM, Bendon RW, et al. Candida funisitis: a clinicopathologic study of 32 cases. Pediatr Dev Pathol 1998;1:118-24.
229. Barth T, Broscheit J, Bussen S, et al. Maternal sepsis and intrauterine fetal death resulting from Candida tropicalis chorioamnionitis in a woman with a retained intrauterine contraceptive device. Acta Obstet Gynecol Scand 2002;81:981-2.
230. Crawford JT, Pereira L, Buckmaster J, et al. Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis. J Matern Fetal Neonatal Med 2006;19:667-70.
231. Kim SK, Romero R, Kusanovic JP, et al. The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med 2010;38:45-53.
232. Canpolat FE, Cekmez F, Tezer H. Chorioamnionitis and neonatal sepsis due to Candida tropicalis. Arch Gynecol Obstet 2011;283:919-20.
233. Pineda C, Kaushik A, Kest H, et al. Maternal sepsis, chorioamnionitis, and congenital Candida kefyr infection in premature twins. Pediatr Infect Dis J 2012;31:320-2.
234. DiGiulio DB. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med 2012;17:2-11.
235. Jackel D, Lai K. Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilization pregnancy: case report and review. Clin Infect Dis 2013;56:555-8.
236. Ito F, Okubo T, Yasuo T, et al. Premature delivery due to intrauterine Candida infection that caused neonatal congenital cutaneous candidiasis: a case report. J Obstet Gynaecol Res 2013;39:341-3.
237. Iwatani S, Mizobuchi M, Sofue T, et al. Neonatal leukemoid reaction associated with Candida albicans chorioamnionitis. Pediatr Int 2014;56:277-9.
238. McLean LK, Chehab FF, Goldberg JD. Detection of viral deoxyribonucleic acid in the amniotic fluid of low-risk pregnancies by polymerase chain reaction. Am J Obstet Gynecol 1995;173:1282-6.
239. Van den Veyver IB, Ni J, Bowles N, et al. Detection of intrauterine viral infection using the polymerase chain reaction. Mol Genet Metab 1998;63:85-95.
240. Wenstrom KD, Andrews WW, Bowles NE, et al. Intrauterine viral infection at the time of second trimester genetic amniocentesis. Obstet Gynecol 1998;92:420-4.
241. Baschat AA, Towbin J, Bowles NE, et al. Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med 2003;13:381-4.
242. Gervasi MT, Romero R, Bracalente G, et al. Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. J Matern Fetal Neonatal Med 2012;25:2002-13.
243. Naresh A, Simhan H. Absence of viruses in amniotic fluid of women with PPROM: a case series. J Reprod Immunol 2012;96:79-83.
244. Bopegamage S, Kacerovsky M, Tambor V, et al. Preterm prelabor rupture of membranes (PPROM) is not associated with presence of viral genomes in the amniotic fluid. J Clin Virol 2013;58:559-63.
245. Cardenas I, Means RE, Aldo P, et al. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 2010;185:1248-57.
246. Cardenas I, Mor G, Aldo P, et al. Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol 2011;65:110-17.
247. Racicot K, Cardenas I, Wunsche V, et al. Viral infection of the pregnant cervix predisposes to ascending bacterial infection. J Immunol 2013;191:934-41.
248. Kwon JY, Romero R, Mor G. New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol 2014;71:387-90.
249. Romero R, Mazor M, Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991;165:969-71.
250. Romero R, Tartakovsky B. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 1992;167:1041-5.
251. Gotsch F, Romero R, Chaiworapongsa T, et al. Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition. J Matern Fetal Neonatal Med 2008;21:605-16.
252. Saglam A, Ozgur C, Derwig I, et al. The role of apoptosis in preterm premature rupture of the human fetal membranes. Arch Gynecol Obstet 2013;288:501-5.
253. Jaiswal MK, Agrawal V, Mallers T, et al. Regulation of apoptosis and innate immune stimuli in inflammation-induced preterm labor. J Immunol 2013;191:5702-13.
254. Lappas M. Caspase-1 activation is increased with human labour in foetal membranes and myometrium and mediates infection-induced interleukin-1beta secretion. Am J Reprod Immunol 2014;71:189-201.
255. Vintzileos AM, Campbell WA, Nochimson DJ, et al. The fetal biophysical profile in patients with premature rupture of the membranes - an early predictor of fetal infection. Am J Obstet Gynecol 1985;152:510-16.
256. Vintzileos AM, Feinstein SJ, Lodeiro JG, et al. Fetal biophysical profile and the effect of premature rupture of the membranes. Obstet Gynecol 1986;67:818-23.
257. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol 1986;68:488-94.
258. Vintzileos AM, Bors-Koefoed R, Pelegano JF, et al. The use of fetal biophysical profile improves pregnancy outcome in premature rupture of the membranes. Am J Obstet Gynecol 1987;157:236-40.
259. Hovick Jr TJ, Vintzileos AM, Bors-Koefoed R, et al. Use of the fetal biophysical profile in severe oligohydramnios after preterm premature rupture of the membranes. J Reprod Med 1989;34:353-6.
260. Fleming AD, Salafia CM, Vintzileos AM, et al. The relationships among umbilical artery velocimetry, fetal biophysical profile, and placental inflammation in preterm premature rupture of the membranes. Am J Obstet Gynecol 1991;164:38-41.
261. Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG 2005;112:32-7.
262. rd LC. Antenatal corticosteroids in women with preterm premature rupture of the membranes. Clin Perinatol 2001;28:797-805.
263. Johnston MM, Sanchez-Ramos L, Vaughn AJ, et al. Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial. Am J Obstet Gynecol 1990;163:743-7.
264. Christmas JT, Cox SM, Andrews W, et al. Expectant management of preterm ruptured membranes: effects of antimicrobial therapy. Obstet Gynecol 1992;80:759-62.
265. Owen J, Groome LJ, Hauth JC. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Am J Obstet Gynecol 1993;169:976-81.
266. Lewis DF, Fontenot MT, Brooks GG, et al. Latency period after preterm premature rupture of membranes: a comparison of ampicillin with and without sulbactam. Obstet Gynecol 1995;86:392-5.
267. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995;346:1271-9.
268. Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-95.
269. Lovett SM, Weiss JD, Diogo MJ, et al. A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997;176:1030-8.
270. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357:979-88.
271. Ovalle A, Martinez MA, Kakarieka E, et al. Antibiotic administration in patients with preterm premature rupture of membranes reduces the rate of histological chorioamnionitis: a prospective, randomized, controlled study. J Matern Fetal Neonatal Med 2002;12:35-41.
272. Kenyon S, Taylor DJ, Tarnow-Mordi WO. ORACLE - antibiotics for preterm prelabour rupture of the membranes: short-term and long-term outcomes. Acta Paediatr Suppl 2002;91:12-15.
273. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008;372:1310-18.
274. Gomez R, Romero R, Nien JK, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med 2007;20:167-73.
275. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol 1986;67:579-83.
276. Romero R, Emamian M, Quintero R, et al. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988;159:114-19.
277. Gauthier DW, Meyer WJ. Comparison of gram stain, leukocyte esterase activity, and amniotic fluid glucose concentration in predicting amniotic fluid culture results in preterm premature rupture of membranes. Am J Obstet Gynecol 1992;167:1092-5.
278. Coultrip LL, Grossman JH. Evaluation of rapid diagnostic tests in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1992;167:1231-42.
279. Romero R, Emamian M, Wan M, et al. The value of the leukocyte esterase test in diagnosing intra-amniotic infection. Am J Perinatol 1988;5:64-9.